Tumor-intrinsic PD-1 is also expressed in a subset of PDL-1+ cells in a broad range of cancer types; the two act in cis (when present on the same cancer cell) and suppress cancer cell proliferation in vitro in the absence of adaptive immunity. Here, RPL17 is linked to neoplasm.